Skip to main content
. 2021 Nov 13;57(11):1241. doi: 10.3390/medicina57111241

Figure 1.

Figure 1

(A) Oncoprint including pathogenic alterations detected in the five analyzed samples. (B) Venn diagram of the alterations detected in the long survival samples (primary CRC and the two metastatic samples). (C) Venn diagram of the alterations detected in the short survival samples (primary CR Cand metastatic samples). LS_prim: primary tumor of the long survival case; LS_1met, LS_2met: metastatic samples of the long survival case; SS_prim: primary tumor of the short survival case; SS_met: metastatic sample of the short survival patient.